Peter Michalos

About Peter Michalos

Peter Michalos is a board member of Rua Diagnostics, which is developing a portable breath test for disease. His focus there is business development and strategy.

He is a physician. Optimus Healthcare Services made him a director in August 2023 and interim executive chairman in January 2025. He was earlier chief of surgery and president of the medical staff at his community hospital. In July 2026, all of Optimus's directors and officers planned to resign effective August 5, 2026, as it wound down.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Peter Michalos in the role, so the role may have started earlier or lasted longer.

Rua Diagnostics Inc. Current

Board Member, Business Development & Strategy

2026 – Present · Westbury, NY

Develops a breath test that uses gas chromatography and machine learning to look for disease.

OI

Optimus Healthcare Services, Inc.

Interim Executive Chairman

From 2023

Key Colleagues at Startups

The people Peter Michalos works with at each company, as listed on that company's latest Form D.

Rua Diagnostics Inc. · Form D, May 27, 2026

Jillian Levovitz

Chief Executive Officer and President

Kenneth Orr

Board Co-Chair

David Goone

Board Member

Jonathan Orr

Board Chair

Sources

1. SECRua Diagnostics Inc. Form D, filed May 27, 2026
2. SEC filingOptimus Healthcare Services S-1/A, July 2024 (directors and officers)
3. SEC filingOptimus Healthcare Services 8-K of 2025-01-22: interim executive chairman from January 15, 2025
4. SEC filingOptimus Healthcare Services 8-K, July 17, 2026 (wind down; all directors and officers resign effective August 5, 2026)